Diabetic Macular Edema Management
OptometryThen, Now, and Tomorrow: Evolving the Management of Diabetic: Retinopathy and the Role of the Optometrist
0.5 COPE
April 06, 2020
The accreditation for this activity has expired.
Primary Audience:
Optometrists
Relevant Terms:
Diabetic macular edema, Macular edema, Diabetic retinopathy, Retinopathy
Eric Nudleman, MD, PHD
Shiley Eye Institute
University of California San Diego
La Jolla, California
| 1. | Understand the evolving treatment paradigm of diabetic eye disease. | 2. | Explain to patients the need for early and timely referral to retina specialists. |
| 1. | Understand the evolving treatment paradigm of diabetic eye disease. |
| 2. | Explain to patients the need for early and timely referral to retina specialists. |
This course is COPE approved for .5 hours of CE Credit for Optometrists.
COPE Course ID: 67765-PS
COPE Activity ID #119209
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflict of interests relating to the topics of this educational activity. Evolve has full policies in place that will identify and resolve all conflicts of interest prior to this educational activity.
Faculty and Disclosures
Eric Nudleman, MD, PhD
Shiley Eye Institute
University of California San Diego
La Jolla, California
Eric Nudleman, MD, PhD, and/or spouse; has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon, Allergan, and Regeneron.
The staff and planners involved in this activity have no financial relationships with commercial interests.
This educational activity is supported by a medical educational grant from Regeneron Pharmaceuticals and Carl Zeiss Meditec.
Off-Label Statement
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, Regeneron Pharmaceuticals or Carl Zeiss Meditec.
COURSE VIEWING REQUIREMENTS
| Supported Browsers: Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8 and above Google Chrome 28.0+ for Windows, Mac OS, or Linux Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux Safari 6+ for Mac OSX 10.7 and above For video playback, install the latest version of Flash or Quicktime. | Supported Phones & Tablets: Android 4.0.3 and above iPhone/iPad with iOS 6.1 or above |
© 2007-2024 HealthCourse, Inc. All rights reserved.
